Neuren Pharmaceuticals Ltd. (NEU.AX), a company that developes new therapies for brain injury, cancer etc., Friday announced that Joseph Horrigan has joined the company as the Vice President of clinical development and medical affairs.
Horrigan recently worked at Autism Speaks as Assistant Vice President and Head of Medical Research. In that role, he oversaw the organization's medical research and training programs including consulting with academic and industry groups on clinical trial design and endpoints in neurodevelopmental disorders.
From 2002 until he joined Autism Speaks, Horrigan coordinated paediatric drug development in the Neurosciences Medicines Development Center at GlaxoSmithKline.
by RTT Staff Writer
For comments and feedback: firstname.lastname@example.org